BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE HIP (COBRAVI-Q)

• Autor(a) principal: SOUSA,EDUARDO BRANCO DE
• Data de Publicação: 2022
• Outros Autores: HAMDAN,PAULO CÉSAR, MENEGASSI,ZARTUR JOSÉ BARCELOS, ALCHAAR,ADRIENI ANTUNES DO AMARAL, TIEPPO,ANTONIO MARTINS, SOUZA,CAIO GONÇALVES DE, PINHEIRO,CARLOS BRUNO REIS, ALMEIDA JÚNIOR,CYRO SCALA DE, ROCHA,EDUARDO DE MELO CARVALHO, CUNHA,FABIANO GONÇALVES, PACHECO,IVAN, REZENDE,MARCIA UCHÔA DE, SOUZA,MÁRCIO PASSINI GONÇALVES DE, BRITTO DA SILVA,MARCOS, CAMPOS,GUSTAVO CONSTANTINO DE
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Acta Ortopédica Brasileira (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-78522022002500301
• topic: Osteoarthritis; Hip; Viscosupplementation; Injections, Intra-Articular

ABSTRACT Objective: The Brazilian Consensus on Hip Viscosupplementation aims to generate a referential and consensual source from the theoretical knowledge and clinical experience of specialists in the field. Methods: A multidisciplinary panel was formed with 15 specialists (sports medicine, orthopedists, physiatrists and rheumatologists), based on clinical and academic experience in the use of viscosupplementation of the hip. 12 statements were prepared, discussed and voted. Each panelist gave a value between 0 and 10 on a Likert scale, specifying their level of agreement with the statement. Results: The panel reached a consensus on several aspects of viscosupplementation of the hip, with emphasis on the following statements: best indication is for mild to moderate hip arthrosis; it may be indicated in severe osteoarthritis; results may vary according to the characteristics of the viscosupplement used; Viscosupplementation should not be performed as an isolated procedure, but in conjunction with other rehabilitation and pharmacological measures; best injection technique should be based on anatomical references coupled with imaging guidance; it is a cost-effective procedure. Conclusion: Viscosupplementation is a safe and effective therapy for hip osteoarthritis, even in severe cases. Guided injection is recommended. Level of Evidence V, Expert Opinion.